Balinge, Sweden

Rolf E Axen


Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 359(Granted Patents)


Location History:

  • Balinge, SE (1979 - 1987)
  • Uppsala, SE (1987)
  • Upplands Balinge, SE (1987)
  • Upsala, SE (1992)

Company Filing History:


Years Active: 1979-1992

Loading Chart...
11 patents (USPTO):Explore Patents

Title: **Rolf E Axen: Innovator in Therapeutically Active Compounds**

Introduction

Rolf E Axen, an esteemed inventor based in Balinge, Sweden, has made significant contributions to the field of therapeutically active compounds. With a total of 11 patents to his name, Axen is recognized for his innovative approaches and profound understanding of organic chemistry.

Latest Patents

Rolf E Axen's latest patents focus on the development of therapeutically active organic compounds. These inventions exhibit unique structural characteristics, particularly those encompassing the radical structure --S'--S'--R. His patents detail methods for modifying these organic compounds to enhance their physiological acceptability while stabilizing them through tautomerism or resonance. His work also involves the creation of pharmaceutical compositions that effectively treat diseases through innovative compounds, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Rolf E Axen has worked with notable companies such as Pharmacia Diagnostics AB and Pharmacia Fine Chemicals AB. His extensive experience in the pharmaceutical industry has equipped him with the skills necessary to innovate within his field, contributing to the development of effective therapeutic agents.

Collaborations

Axen has collaborated with talented colleagues, including Jan P Carlsson and Hakan N Drevin. These partnerships reflect his ability to foster teamwork in pursuit of groundbreaking research and invention within the pharmaceutical domain.

Conclusion

Rolf E Axen stands out as an influential figure in the field of therapeutically active compounds. His patents and collaborations exemplify a dedication to innovation that aims to improve health outcomes for mammals, including humans. As he continues to push the boundaries of organic chemistry, his work serves as an inspiration for future inventors in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…